US dollar weakens as trade war fears and Fed independence concerns pressure sentiment. EUR/USD may resume an uptrend if price holds above the 1.17 resistance zone. US GDP and PCE data could shape rate ...

Investing.com -- Big Yellow Group reported third-quarter revenue of £52.3 million, up from £51 million a year earlier, as higher net rents helped offset lower occupancy during a seasonally weaker ...

Investing.com - European stocks retreated Tuesday, adding to the previous session’s sharp losses as the concern of further ...

Investing.com -- Midwich Group plc (LON:MIDW), a global specialist audio visual distributor, on Tuesday reported its full-year 2025 revenue is expected to be approximately £1.3 billion, matching 2024 ...

Under the agreement, Shionogi will increase its holding in ViiV Healthcare to 21.7%, while GSK will maintain a 78.3% stake. To facilitate this change, ViiV Healthcare will issue new shares to Shionogi ...

The French energy major said fourth-quarter oil and gas production is expected to rise nearly 5% year on year, driven by ...

The rupiah has fallen nearly 2% against the dollar in January, placing it among the worst performing emerging Asian ...

Outside Europe, Renault brand sales rose 11.7%, driven by growth in Latin America, South Korea and Morocco. Sales increased 11.3% in Latin America, 55.9% in South Korea and 44.8% in Morocco.

Investing.com -- DocMorris AG (SIX:DOCM) on Tuesday reported an 11.1% rise in 2025 external revenue, driven by stronger growth in the fourth quarter. The Dutch online pharmacy’s external revenue ...

The world’s largest currency largely wiped out a mid-January recovery, moving back in sight of lows seen at the beginning of the year as traders favored physical, safe-haven assets such as gold.

The Bank of England has indicated that unemployment may remain around the 5% level for the next two years, while economists in a recent survey by the Times newspaper predicted that unemployment could ...

Investing.com -- Japan’s Shionogi & Co (TYO:4507) said on Tuesday it would pay $2.13 billion for new shares in joint venture ViiV Healthcare, increasing its stake in the HIV drugmaker to 21.7% as U.S.